Wearable lower-limb exoskeleton to stretch legs and improve walking

Leg Stretching Using a Controllable Wearable Exoskeleton on Demand for People With Spasticity

Not applicable Interventional VA Office of Research and Development · NCT05926596

This research will test a portable wearable exoskeleton to help people with spasticity from spinal cord injury increase leg range of motion and improve walking.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment10 (estimated)
Ages18 Years and up
SexAll
SponsorVA Office of Research and Development Federal
Locations1 site (Syracuse, New York)
Trial IDNCT05926596 on ClinicalTrials.gov

What this trial studies

The project develops a protocol using a fully wearable, portable lower‑limb exoskeleton and body sensors to support leg motion and stretching. Participants will perform guided leg‑stretching, treadmill walking, and overground walking while researchers record muscle activity, joint motion, and gait performance. The study enrolls people with neurological movement deficits, primarily veterans with spinal cord injury who are neurologically stable at least six months after injury. The overall aim is to refine an effective assistance strategy that can restore range of motion and gait ability and reduce caregiver burden.

Who should consider this trial

Good fit: Ideal candidates are veterans with spasticity from spinal cord injury at least six months post‑injury who are neurologically stable, can wear the device and sensors, and can provide informed consent.

Not a fit: People with other active neurological disorders, recent hip/knee pain or injuries that limit mobility, pregnancy, weight over 300 lbs, or unresolved surgical recovery are unlikely to benefit from this protocol.

Why it matters

Potential benefit: If successful, the device could increase leg range of motion, reduce spasticity‑related gait problems, and improve independence and quality of life.

How similar studies have performed: Robotic and exoskeleton‑assisted gait training has shown promise for improving mobility in some populations, but fully wearable on‑demand exoskeleton approaches for spasticity are still emerging and less well established.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Veteran individuals with spasticity due to spinal cord injury (SCI) at least 6 months post SCI
* Capable of providing informed consent and reporting age, gender, and neurological condition
* Neurologically stable (\>6 months post-SCI) and can wear the device and the sensors, provide written informed consent, and follow instruction

Exclusion Criteria:

* Participants should not experience another neurological disorder except their primary diagnosed neurological condition (spinal cord injury)
* Participants should not be pregnant
* Participants should weigh less than 300 lbs
* Participants should not have experienced signs of hip/knee pain during the past 2-3 weeks that limits mobility (i.e., reaching, walking, lifting, etc.)
* Participants should be recovered from any previous surgical interventions, joint injuries, muscle strain, or extreme muscle soreness following surgery
* Participants should not take medications known to affect bone metabolism, muscle strength or cardiovascular performance or have any ailments causing high fever, high blood pressure, or high heart rate

Where this trial is running

Syracuse, New York

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions SpasticityMovement DisordersSpinal Cord Injuryexoskeletonspasticity
Last reviewed 2026-06-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.